# An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

> **NCT00307619** · PHASE3 · COMPLETED · sponsor: **Janssen-Cilag Farmaceutica Ltda.** · enrollment: 73 (actual)

## Conditions studied

- Binge Eating

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00307619
- **Lead sponsor:** Janssen-Cilag Farmaceutica Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2011-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307619, "An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00307619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*